CVE-2024-34398

CVE-2024-34398 is a medium-severity vulnerability in Bmc Remedy Mid-tier with a CVSS 3.x base score of 4.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-80.

Key facts

Description

An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers.

Frequently asked questions

What is CVE-2024-34398?
An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers.
How severe is CVE-2024-34398?
CVE-2024-34398 has a CVSS 3.x base score of 4.2, rated medium severity. It is exploitable over network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-34398 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (14th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-34398?
CVE-2024-34398 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-34398?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-34398 have an EU (EUVD) identifier?
Yes. CVE-2024-34398 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-54199.
When was CVE-2024-34398 published?
CVE-2024-34398 was published on 2025-03-12 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Bmc Remedy Mid-tier

All CVEs affecting Bmc Remedy Mid-tier →

Other CWE-80 vulnerabilities

Browse all CWE-80 vulnerabilities →